Abstract
Maternal depression affects a mother and her baby. However, treatment with antidepressants during pregnancy may pose risks. Optimal care of depression during pregnancy would be efficacious and safe for both mother and baby. Treatments that provide additional health benefits to the mother and baby would be ideal. Currently there are no evidence-based guidelines to inform the use of antidepressant medications in pregnancy and postpartum. Some women may be unwilling to accept standard antidepressant medications in pregnancy because the long-term effects on the child are unknown. Omega-3 fatty acids are natural compounds with many established health benefits. The safety of omega-3 fatty acids in pregnancy has been demonstrated, and specific health benefits during pregnancy have been associated with their use. Epidemiological data, treatment data and biochemical rationale support the research of omega-3 fatty acids for depression during pregnancy.
Similar content being viewed by others
References
Adams PB, Lawson S, Sanigorski A et al. 1996. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids, 31(Suppl):S157–61.
Aggett PJ, Haschke F, Heine W et al. 1991. ESPGAN comment of the content and composition of lipids in infant formula. Acta Paediatr Scand, 80:887–96.
Al MD, Van Houwelingen AC, Kester ADM et al. 1995. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr, 74:55–68.
Ambrosone CB, Freudenheim JL, Sinha R et al. 1998. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer, 16:825–30.
Anderson CM. 1999. Achieving breastfeeding success. Simple solutions to common concerns. Adv Nurse Pract, 7(11):67–9.
Appleby L, Warner R, Whitton A et al. 1997. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ, 314:932–9.
Araya J, Rojas M, Fernandez P et al. 1998. Essential fatty acid content of maternal erythrocyte phospholipids. A study in preterm and full-term human newborns. Rev Med Child, 126:391–6.
Asberg M, Traskman L, Thoren P. 1976. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry, 33:1193–7.
Auestad N, Montalto MB, Hall RT et al. 1997. Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year. Ross pediatric lipid study. Pediatr Res, 41:1–10.
Baur LA, O’Connor J, Pan DA et al. 2000. Relationships between the fatty acid composition of muscle and erythrocyte membrane phospholipid in young children and the effect of type of infant feeding. Lipids, 35: 77–82.
Belluzzi A, Brignola C, Campieri M et al. 1996. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med, 334:1557–60.
Benisek D, Shabert J, Skornik R. 2000. Dietary intake of polyunsaturated fatty acids by pregnant or lactating women in the United States. Obstet Gynecol, 95:77–8.
Birch EE, Garfield S, Hoffman DR et al. 2000. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol, 42: 174–81.
British Nutrition Foundation. 1992. Unsaturated fatty acids: nutritional and physiological significance. London: Chapman Hall.
Broughton KS, Johnson CS, Pace BK et al. 1997. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr, 65:1011–17.
Calder PC. 1997. N-3 polyunsaturated fatty acids and cytokine production in health and disease. N Engl J Med, 41:203–34.
Chambers CD, Johnson KA, Kick LN et al. 1996. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med, 335:1010–15.
Cicchetti D, Rogosch FA, Toth SL. 1988. Maternal depressive disorder and contextual risk: contributions to the development of attachment insecurity and behavioral problems in tottlerhood. Dev Psychopathol, 10:283–300.
Cohen LS. 1997. Treatment of psychiatric illness during pregnancy and the postpartum period. In Program of the 150th Annual Meeting of the American Psychiatric Association. 1997 May 18; San Diego, CA. p11.
Cohen LS, Heller VL, Bailey JW et al. 2000. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry, 48:996–1000.
Costei AM, Kozer E, Ho T et al. 2002. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med, 156: 1129–32.
Coull MA, Lowther S, Katona CL et al. 2000. Altered brain protein kinase C in depression: a post-mortem study. Eur Neuropsychopharmacol, 10:283–8.
Dayan J, Creveuil C, Herlicoviez M et al. 2002. Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol, 155:293–301.
Edwards R, Peet M, Shay J et al. 1998. Omega-3 polyunsaturated fatty acids in the diet and in the red blood cell membranes of depressed patients. J Affect Disord, 48:149–55.
Endres S. 1996. N-3 polyunsaturated fatty acids and human cytokine synthesis. Lipids, 31:S239–42.
Ericson A, Kallen B, Wiholm B. 1999. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol, 55: 503–8.
Evans J, Heron J, Francomb H et al. 2001. Cohort study of depressed mood during pregnancy and after childbirth. BMJ, 323:257–60.
FAO/WHO Expert Committee. 1994. The role of essential fatty acids in neural development: implications for perinatal nutrition. Am J Clin Nutr, 57:703–10.
Fernstrom JD. 2000. Can nutrient supplements modify brain function? Am J Clin Nutr, 71:1669–73.
Foreman-Van Drongelen M, Van Houwelingen AC, Kester ADM et al. 1996. Influence of feeding artificial-formula milks containing docohexaenoic and arachidonic acids on the postnatal long-chain polyunsaturated fatty acid status of healthy preterm infants. Br J Nutr, 76:649–67.
Gartside PS, Wang P, Glueck CJ. 1998. Prospective assessment of coronary heart disease risk factors: the NHANES I epidemiologic follow-up study (NHEFS) 16-year follow-up. J Am Coll Nutr, 17:263–9.
Gregoire AJP, Kumar R, Everitt B et al. 1996. Transdermal oestrogen for treatment of severe postnatal depression. Lancet, 347:930–3.
Harris WS, Connor WE, Linsey S. 1984. Will dietary omega-3 fatty acids change the composition of breast milk? Am J Nutr, 40:780–5.
Hendrick V, Smith LM, Suri R et al. 2003. Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol, 188: 812–15.
Hendrick V, Stowe ZN, Altshuler LL et al. 2003. Placental passage of antidepressant medications. Am J Psychiatry, 160:993–6.
Hibbeln JR. 1998. Fish consumption and major depression. Lancet, 351: 1213.
Hibbeln JR. 2002. Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord, 69:15–29.
Hibbeln JR, Linnoila M, Umhau JC et al. 1998. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry, 44:235–42.
Hoffman DR, Uauy R. 1992. Essentiality of dietary n-3 fatty acids for premature infants: plasma and red blood cell fatty acid composition. Lipids, 27:886–95.
Holman RT, Johnson SB, Ogburn PL. 1991. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci USA, 88:4835–9.
Horrobin DF, Peet M. 2002. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry, 59:913–19.
Iso H, Rexrode KM, Stampfer MJ et al. 2001. Intake offish and omega-3fatty acids and risk of stroke in women. JAMA, 285:304–12.
ISSFAL Board of Directors. 1994. Recommendations for the essential fatty acid requirement for infant formula. ISSFAL Newsletter, 1:4–5.
Istvan J. 1986. Stress, anxiety, and birth outcomes: a critical review of the evidence. Psychol Bull, 100:331–48.
Kalmijn S, Launer LJ, Ott A et al. 1997. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol, 42:776–82.
Kelly VE, Ferretti A, Izui S. 1985. A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MPL-1pr mice. J Immunol, 134:1914–19.
Khalfoun B, Thibault F, Watier H et al. 1997. Docosahexanoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6.Adv Exp Med Biol,400B:589–97.
Kinsella JE. 1990. Lipids, membrane receptors, and enzymes: effects of dietary fatty acids. J Parenteral Enteral Nutr, 14:200S–217S.
Kremer JM, Lawrence DA, Petrillo GF et al. 1995. Effects of high dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis Rheum, 38:1107–14.
Kulin NA, Pastuszak A, Sage SR et al. 1998. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA, 279:609–10.
Labbok MH. 2001. Effects of breastfeeding on the mother. Pediatr Clin North Am, 48:143–58.
Leslie CA, Gonnerman WA, Ullman MD. 1985. Dietary fish oil modulates macrophage fatty acids and decreases susceptibility in mice. J Exp Med, 162:1336–49.
Maes M, Delange J, Ranjan R et al. 1997. Acute phase proteins in schizophrenia, mania, and major depression: modulation by psychotropic drugs. Psychiatry Res, 66:1–11.
Maes M, Meltzer H, Jacobs J et al. 1993. Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatr Scand, 87:160–6.
Maes M, Smith R, Christophe A et al. 1996. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord, 38:35–46.
Maes M, Stevens WJ, Declerck LS et al. 1993. Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry, 17:241–55.
Maes M, Verkerk R, Vandoolaeghe E et al. 1997. Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. Eur Arch Psychiatr Clin Neurosci, 247:154–61.
Marangell LB, Martinez JM, Zboyan HA et al. 2003. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 160: 996–8.
Meydani SN. 1996. Effect of n-3 polyunsaturated fatty acids on cytokine production and their biologic function. Nutrition, 12:S8–14.
Min Y, Ghebremeskel K, Crawford MA et al. 2000. Pregnancy reduces arachidonic and docosahexaenoic in plasma triacylglycerols of Korean women. Int J Vitam Nutr Res, 70:70–5.
Mirnikjoo B, Brown SE, Seung Kim HF et al. 2001. Protein kinase inhibition by omega-3 fatty acids. J Biol Chem, 276:10888–96.
Mohan CG, Moore JJ. 2000. Fluoxetine toxicity in a preterm infant. J Perinatol, 20:445–6.
Morris MC, Sacks F, Rosner B. 1993. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation, 88:523–33.
Murray L, Fiori-Cowley A, Hooper R et al. 1996. The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev, 67:2512–26.
Nemets B, Stahl Z, Belmaker RH. 2002. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry, 159:477–9.
Nonacs R, Cohen LS. 1998. Postpartum mood disorders: diagnosis and treatment guidelines. J Clin Psychiatry, 59:34–40.
Nordeng H, Lindemann R, Perminov KV et al. 2001. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr, 90:288–91.
Nulman I, Rovet J, Stewart DE et al. 1997. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med, 336:258–62.
Olsen SF. 1993. Consumption of marine n-3 fatty acids during pregnancy as a possible determinant of birth weight. Epidemiol Rev, 15:399–413.
Olsen SF, Sorensen JD, Secher NJ et al. 1992. Randomised controlled trial of effect of fish oil supplementation on pregnancy duration. Lancet, 339:1003–4.
Otto SJ, Van Houwelingen AC, Antal M et al. 1997. Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur J Clin Nutr, 51:232–42.
Peet M, Murphy B, Shay J et al. 1998. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry, 43:315–19.
Petridou E, Koussouri M, Toupadaki N et al. 1998. Diet during pregnancy and the risk of cerebral palsy. Br J Nutr, 79:407–12.
Popoli M, Brunello N, Perez J et al. 2000. Second messenger-related protein kinases in the brain: their functional role and the action of antidepressant drugs. J Neurochem, 74:21–3.
Scott DT, Janowsky JS, Carroll RE et al. 1998. Formula supplementation with long-chain polyunsaturated fatty acids: are there developmental benefits? Pediatrics, 102:59.
Sher L. 2002. Prevention of the serotonin reuptake inhibitor discontinuation syndrome. Med Hypotheses, 59:92–4.
Simon GE, Cunningham ML, Davis RL. 2002. Outcomes of prenatal antidepressant exposure. Am J Psychiatry, 159:2055–61.
Simopoulos AP. 1991. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr, 54:438–63.
Siscovick DS, Raghunathun TE, King I et al. 1996. Dietary intake and cell membrane levels and the risk of primary cardiac arrest. JAMA, 275:836–7.
Smith RS. 1991. The macrophage theory of depression. Med Hypotheses, 35:298–306.
Song C, Lin A, Bonaccorso S et al. 1998. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord, 49: 211–19.
Stowe ZN, Casarella J, Landrey J et al. 1995. Sertraline in the treatment of women with postpartum major depression. Depression, 3:49–55.
Su KP, Huang SY, Chiu CC et al. 2003. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol, 13:267–71.
Tanskanen A, Hibbeln JR, Hintikka J et al. 2001. Fish consumption, depression and suicidality in a general population. Arch Gen Psychiatry, 58:512–13.
Tanskanen A, Hibbeln JR, Tuomilehto J et al. 2001. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv, 52:529–31.
Tremoli E, Maderna P, Marangoni F et al. 1995. Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers. Am J Clin Nutr, 61:607–13.
Van Houwelingen AC, Sorensen JD, Hornstra G et al. 1995. Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. Br J Nutr, 74:723–31.
Veierod MB, Laake P, Thelle DS. 1997. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev, 6:540–9.
Wadhwa PD, Sandman CA, Porto M et al. 1993. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol, 169:858–65.
Webster J, Pritchard MA, Linnane LW et al. 2001. Postnatal depression: use of health care services and satisfaction with health care providers. J Qual Clin Pract, 21:144–8.
Weissman MM, Leaf PJ, Holzer CE et al. 1984. The epidemiology of depression. An update of sex differences in rates. J Affect Disord, 7: 179–88.
Williams MA, Zingham RW, King IB et al. 1995. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology, 6: 232–7.
Wisner KL, Zarin DA, Holmboe ES et al. 2000. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry, 157:1933–40.
Yamashita N, Maruyama M, Yamazaki K et al. 1991. Effect of eicosapentaenoic and docosahexaenoic acid on natural killer cell activity in human peripheral blood lymphocytes. Clin Immunol Immunopathol, 59:335–45.
Vestergaard M, Obel C, Henriksen TB et al. 1999. Duration of breastfeeding and developmental milestones during the latter half of infancy. Acta Paediatr, 88:1327–32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Freeman, M.P. Omega-3 fatty acids: an ideal treatment for depression in pregnancy?. Evid-Based-Integrative-Med 1, 43–49 (2004). https://doi.org/10.2165/01197065-200301010-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/01197065-200301010-00008